7 completed, 3 active not recruiting, 2 recruiting, 1 terminated. 5 Phase 2, 2 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Active not recruiting 1, Recruiting 1, Terminated 1 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Follicular Thyroid Cancer: new trials by email Literature Review of Follicular Thyroid Cancer trials Research Report on Follicular Thyroid Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Incidental Thyroid Cancer in Cases With Inflammatory Thyroid Lesion total thyroidectomy - Papillary Thyroid Cancer, Hashimoto Disease | Not applicable | Completed | Minia University | 98 | 2025-02-01 | 2026-08-11 |
| Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC Selpercatinib, Sodium Iodine I-131, rhTSH - Thyroid Cancer, Thyroid Carcinoma | Phase 2 | Recruiting | Massachusetts General Hospital | 30 | 2023-03-01 | 2024-12-12 |
| Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer Thyroid Cancer, Follicular Thyroid Cancer | Active not recruiting | National Taiwan University Hospital | 50 | 2022-08-01 | 2026-04-13 | |
| Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer Thyroid Cancer, Papillary Thyroid Cancer | Active not recruiting | National Taiwan University Hospital | 103 | 2021-08-19 | 2026-04-13 | |
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer Trametinib, Dabrafenib, PDR001 - Thyroid Cancer, Thyroid Cancer, Follicular | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 19 | 2020-09-02 | 2026-09-17 |
| Psychological Impact of a Sophrological Accompaniment During the Announcement of Thyroid Cancer sophrology sessions - Follicular Thyroid Cancer | Not applicable | Unknown | Assistance Publique Hopitaux De Marseille | 232 | 2018-09-01 | 2018-08-21 |
| Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer Lenvatinib, Sorafenib, Cabozantinib - Thyroid Cancer, Thyroid Cancer, Medullary | Phase 2 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 6 | 2018-08-06 | 2021-07-14 |
| Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in Follicular Thyroid Tumours Lectin-histochemistry retrospectively performed - Follicular Thyroid Cancer | Completed | National University Health System, Singapore | 37 | 2018-01-01 | 2021-10-01 | |
| Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer dabrafenib, trametinib - Follicular Thyroid Cancer, Insular Thyroid Cancer | Phase 2 | Completed | Bhavana Konda | 53 | 2012-11-07 | 2025-08-24 |
| Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment Malignant Struma Ovarii, Papillary Thyroid Cancer | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 16 | 2011-09-20 | 2020-09-28 | |
| A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors rosiglitazone, XL184 - Papillary Thyroid Cancer, Follicular Thyroid Cancer | Phase 1 | Completed | Exelixis | 40 | 2010-04-01 | 2013-09-19 |
| Sutent Adjunctive Treatment of Differentiated Thyroid Cancer SU011248, Sutent - Papillary Thyroid Cancer, Follicular Thyroid Cancer | Phase 2 | Completed | Medstar Health Research Institute | 23 | 2008-04-01 | 2020-08-05 |
| Long-term Survival Outcomes of Total Thyroidectomy and Radioactive Iodine Therapy in Unilateral T3/T4 FTC Total Thyroidectomy (TT), Radioactive iodine treatment(RAIT) - Follicular Thyroid Cancer, SEER Database Analysis | Completed | Dezhou Hospital Qilu Hospital of Shandong University | 2957 | 2000-01-01 | 2024-05-31 | |
| Studies on Tumors of the Thyroid 68-Gallium Dotatate - Hurthle Cell Thyroid Cancer, Tall Cell Variant Thyroid Cancer | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2500 | 1977-06-01 | 2026-10-29 |
Adenocarcinoma, Follicular (14) · Thyroid Cancer, Papillary (10) · Thyroid Neoplasms (9) · Thyroid cancer, Hurthle cell (3) · Adenoma, Oxyphilic (1) · Carcinoma, Medullary (1) · Carcinoma, Renal Cell (1) · Hashimoto Disease (1) · Hypothyroidism (1) · Thyroid Diseases (1) · Thyroid cancer, follicular (1) · Thyroid cancer, medullary (1) · Thyroiditis, Autoimmune (1)
Adenocarcinoma (14) · Carcinoma (14) · Neoplasms (14) · Neoplasms by Histologic Type (14) · Neoplasms, Glandular and Epithelial (14) · Endocrine Gland Neoplasms (11) · Endocrine System Diseases (11) · Head and Neck Neoplasms (11) · Neoplasms by Site (11) · Adenocarcinoma, Papillary (10) · Thyroid Diseases (10) · Thyroid Neoplasms (2) · Adenoma (1) · Autoimmune Diseases (1) · Carcinoma, Neuroendocrine (1)
dabrafenib (2) · trametinib (2) · Iodine-131 (1) · Rosiglitazone (1) · Sorafenib (1) · Sunitinib (1) · Thyrotropin Alfa (1) · cabozantinib (1) · gallium Ga 68 dotatate (1) · lenvatinib (1) · selpercatinib (1) · spartalizumab (1) · vandetanib (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · National Taiwan University Hospital (2) · Assistance Publique Hopitaux De Marseille (1) · Bhavana Konda (1) · Dezhou Hospital Qilu Hospital of Shandong University (1) · Exelixis (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Massachusetts General Hospital (1) · Medstar Health Research Institute (1) · Memorial Sloan Kettering Cancer Center (1) · Minia University (1) · National University Health System, Singapore (1)
United States (8) · Taiwan (2) · Egypt (1) · France (1) · Singapore (1)
Alan L Ho, MD, PhD (1) · Bhavana Konda, MD (1) · Christine H. Chung, M.D. (1) · Joanna Klubo-Gwiezdzinska, M.D. (1) · Kenneth D Burman, MD (1) · Kong Y Chen, Ph.D. (1) · Lori J. Wirth, MD (1) · Tao Zhang, MD (1)
PMID 24827131, PMID 26671977, PMID 31085763, PMID 35658604, PMID 37219859
2014 (1)